AbstractThe therapeutic regimen for small cell lung cancer (SCLC) has changed little in the past several decades. Apatinib is a sm...
AbstractAngiogenesis is the process through which novel blood vessels are formed from pre-existing ones and it is involved in both...
Sub-category:Esophageal or Gastric CancerCategory:Gastrointestinal (Noncolorectal) CancerMeeting:2019 ASCO Annual MeetingAuthor(s)...
AbstractBackground: In China, cervical cancer is the fifth most commonly diagnosed cancer, and the outcomes for patientswith advan...
SummaryBackground Anti-angiogenic therapy combined with chemotherapy could improve the outcomes of patients withplatinum-resistant...
AbstractThe treatment of advanced triple-negative breast cancer, which failed in first-line or second-line therapy, is a significa...
Bevacizumab (Bv) can be used synergistically with fluoropyrimidine‐basedchemotherapy to treat colorectal cancer.Whether and how it...
Introduction: Methylsulfonic apatinib (hereinafter referred to as Apatinib) is a small-molecule angiogenesis inhibitor highly and...
AbstractRationale: Hepatocellular carcinoma (HCC) is a highly invasive cancer associated with high mortality rates. Although soraf...